CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

NRX Pharmaceuticals to Submit Attestation to FDA on Packaging Deficiency for Ketamine Product

RegulatoryNegative
AI Analysis

Summary

NRX Pharmaceuticals will submit an attestation to the FDA addressing a packaging deficiency related to its ketamine product.

Outcome Details

Attestation submission to FDA regarding packaging deficiency

Importance:3/10
Sentiment:
-0.30
FDAregulatorypackagingketamine
Related Companies

Read the original article

Published by yahoo_finance on August 7, 2026 7:03 PM

Read Original